I googled Robert Andrew Finder. This is what I found:
Mr. Robert Andrew Finder, also known as Bob, BSChE, AICD has been Chief Executive Officer and Managing Director of Novozymes Biopharma AU Limited (Formerly, Novozymes GroPep Ltd., & GroPep Limited) since September 2, 2002. Mr. Finder is a chemical engineer with over 35 years business experience in the pharmaceutical and chemical industries. Prior to joining GroPep Limited, he served as President and Chief Operating Officer, Mayne Pharma - Americas and Asia Pacific.
Novozymes sounds like it's doing some interesting things, but I can't see a link between them and what LBT has developed. Maybe someone else can explain....
Ann: Notice of initial substantial holder-LBT.AX, page-2
Add LBT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.001(7.69%) |
Mkt cap ! $23.11M | |||
| Open | High | Low | Value | Volume |
| 1.3¢ | 1.4¢ | 1.3¢ | $12.82K | 927.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 3821763 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.5¢ | 959699 | 5 |
View Market Depth
| Last trade - 15.00pm 17/09/2024 (20 minute delay) ? |
| LBT (ASX) Chart |